References

2025 ESC guidelines for the management of myocarditis and pericarditis

10.1093/eurheartj/ehaf192 · 2025 · External reference

Immune-mediated diseases and risk of incident cardiovascular diseases: a prospective cohort study

10.1093/rheumatology/kead266 · 2024 · External reference

Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases

10.1038/s41584-024-01149-x · 2024 · External reference

Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study

10.1136/bmj-2023-078523 · 2024 · External reference

Cardiovascular manifestations in idiopathic inflammatory myopathies

10.1007/s10067-023-06599-4 · 2023 · External reference

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

10.1093/oxfordjournals.aje.a009122 · 1997 · External reference

Heart and systemic sclerosis-findings from a national cohort study

10.1093/rheumatology/kead599 · 2024 · External reference

Diagnostic criteria, severity classification and guidelines of systemic sclerosis

10.1111/1346-8138.14162 · 2018 · External reference

Cardiac Involvement in Eosinophilic Granulomatosis with Polyangiitis

10.1007/s11886-025-02258-z · 2025 · External reference

Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis

10.1093/rheumatology/keaa742 · 2021 · External reference

Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus

10.1007/s10554-014-0560-3 · 2015 · External reference

Immunological pathogenesis and treatment of systemic lupus erythematosus

10.1007/s12519-019-00229-3 · 2020 · External reference

Idiopathic inflammatory myopathies: clinical approach and management

10.3389/fneur.2016.00064 · 2016 · External reference

Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations

10.1016/j.jacc.2018.09.072 · 2018 · External reference

Tailored therapeutic decision of rheumatoid arthritis using proteomic strategies: how to start and when to stop?

10.1186/s12014-023-09411-2 · 2023 · External reference

Anti-dsDNA antibodies increase the cardiovascular risk in systemic lupus erythematosus promoting a distinctive immune and vascular activation

10.1161/atvbaha.121.315928 · 2021 · External reference

Diagnostic utility of the revised Lake Louise criteria in myocarditis associated with active autoimmune rheumatic disease

10.1016/j.jocmr.2025.101916 · 2025 · External reference

Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry

10.1093/rheumatology/kead368 · 2024 · External reference

Cardiac Involvement in Eosinophilic Granulomatosis with Polyangiitis

10.1007/s11886-025-02258-z · 2025 · External reference

Rationale and design of EACVI-INFLAME study: an international registry on multimodality imaging for suspicion of cardiovascular involvement due to inflammatory or autoimmune rheumatic diseases

10.1016/j.acvd.2025.10.109 · 2026 · External reference